Stem Cells – The Hope, the Hype and the Science

Dr Bahar Ramezanpour, VP Business Development, Hubrecht Organoid Technology, explains the advantages of using organoids over traditional cell culture systems and how they are used to develop therapeutics.

Dr Michael Hennig, CEO of leadXpro AG, discusses the challenges and solutions for the structural determination of membrane proteins.

Hemophilia is a genetic disease that prevents blood from clotting properly leading to prolonged internal and external bleeding. There are existing treatments for hemophilia that require lifelong administration, while gene therapy may offer a one-time treatment to address the cause of the disease.